Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / SR One Capital Management, LP
Form 13F · Q2 2026

SR One Capital Management, LP

CIK 1910264Filed 2026-08-1213F-HR View the filing on EDGAR ↗
$1.0B
Reported book value
15
Positions
12
Quarters on record
Top 50
Positions

SR One Capital Management, LP — holdings

Top 15 positions of 15, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1MANE Veradermics Inc2.4M+0.0%$295M28.4%
2ZBIO Zenas Biopharma Inc5.0M+0.0%$128M12.3%
3CRSP Crispr Therapeutics Ag2.0M+0.0%$111M10.7%
4AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc3.3M—$109M10.5%
5DSGN Design Therapeutics Inc6.5M+0.0%$94M9.1%
6ODTX Odyssey Therapeutics Inc3.8M—$71M6.8%
7ALMS Alumis Inc2.0M+0.0%$55M5.3%
8ORIC Oric Pharmaceuticals Inc4.6M+2.2%$50M4.8%
9MLYS Mineralys Therapeutics Inc1.6M+0.0%$42M4.1%
10SPRY Ars Pharmaceuticals Inc4.0M+0.0%$32M3.1%
11MOBI Mobia Med Inc2.0M—$27M2.6%
12NKTX Nkarta Inc3.3M+0.0%$9M0.9%
13OCS Oculis Holding Ag641,022+0.0%$9M0.9%
14RARE Ultragenyx Pharmaceutical In137,753+0.0%$5M0.4%
15ENGENE HOLDINGS INC Engene Holdings Inc747,750+0.0%$1M0.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.